FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136209958> ?p ?o ?g. }

• W3136209958 endingPage "1516" @default.
• W3136209958 startingPage "1516" @default.
• W3136209958 abstract "We aimed to characterize γ-H2AX and 53BP1 foci formation in patients receiving somatostatin receptor-targeted radioligand therapy, and explored its role for predicting treatment-related hematotoxicity, and treatment response.A prospective analysis of double-strand break (DSB) markers was performed in 21 patients with advanced gastroenteropancreatic neuroendocrine tumors. γ-H2AX and 53BP1 foci formation were evaluated in peripheral blood lymphocytes (PBLs) at baseline, +1 h and +24 h after administration of 7.4 GBq (177Lu)Lu-DOTA-TATE. Hematotoxicity was evaluated using standard hematology. Therapy response was assessed using (68Ga)Ga-DOTA-TATE PET/CT before enrollment and after 2 cycles of PRRT according to the volumetric modification of RECIST 1.1.DSB marker kinetics were heterogeneous among patients. Subclinical hematotoxicity was associated with γ-H2AX and 53BP1 foci formation (e.g., change in platelet count vs change in γ-H2AX+ cells between baseline and +1 h (r = -0.6080; p = 0.0045). Patients showing early development of new metastases had less γ-H2AX (p = 0.0125) and less 53BP1 foci per cell at +1 h (p = 0.0289), and demonstrated a distinct kinetic pattern with an absence of DSB marker decrease at +24 h (γ-H2AX: p = 0.0025; 53BP1: p = 0.0008).Assessment of γ-H2AX and 53BP1 foci formation in PBLs of patients receiving radioligand therapy may hold promise for predicting subclinical hematotoxicity and early treatment response." @default.
• W3136209958 created "2021-03-29" @default.
• W3136209958 creator A5010325047 @default.
• W3136209958 creator A5010436347 @default.
• W3136209958 creator A5011719291 @default.
• W3136209958 creator A5014370655 @default.
• W3136209958 creator A5014956643 @default.
• W3136209958 creator A5027656725 @default.
• W3136209958 creator A5029977875 @default.
• W3136209958 creator A5031324764 @default.
• W3136209958 creator A5074150271 @default.
• W3136209958 date "2021-03-25" @default.
• W3136209958 modified "2023-09-26" @default.
• W3136209958 title "Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors" @default.
• W3136209958 cites W1694492712 @default.
• W3136209958 cites W1914351667 @default.
• W3136209958 cites W1969474286 @default.
• W3136209958 cites W1985775217 @default.
• W3136209958 cites W1986619322 @default.
• W3136209958 cites W2018716777 @default.
• W3136209958 cites W2027676394 @default.
• W3136209958 cites W2036643295 @default.
• W3136209958 cites W2047172711 @default.
• W3136209958 cites W2061414735 @default.
• W3136209958 cites W2070803941 @default.
• W3136209958 cites W2074483662 @default.
• W3136209958 cites W2075158658 @default.
• W3136209958 cites W2082559623 @default.
• W3136209958 cites W2090257199 @default.
• W3136209958 cites W2092195147 @default.
• W3136209958 cites W2096340454 @default.
• W3136209958 cites W2099254999 @default.
• W3136209958 cites W2112704588 @default.
• W3136209958 cites W2125398839 @default.
• W3136209958 cites W2126898119 @default.
• W3136209958 cites W2127733528 @default.
• W3136209958 cites W2145004994 @default.
• W3136209958 cites W2146745189 @default.
• W3136209958 cites W2146917785 @default.
• W3136209958 cites W2168809431 @default.
• W3136209958 cites W2183147143 @default.
• W3136209958 cites W2469466854 @default.
• W3136209958 cites W2490640148 @default.
• W3136209958 cites W2499065405 @default.
• W3136209958 cites W2573369749 @default.
• W3136209958 cites W2614800517 @default.
• W3136209958 cites W2623030379 @default.
• W3136209958 cites W2883664363 @default.
• W3136209958 cites W2899540665 @default.
• W3136209958 cites W2902656640 @default.
• W3136209958 cites W2966007643 @default.
• W3136209958 cites W2978481495 @default.
• W3136209958 cites W2980243084 @default.
• W3136209958 cites W2982446870 @default.
• W3136209958 cites W2996142297 @default.
• W3136209958 cites W2998153760 @default.
• W3136209958 cites W3016045163 @default.
• W3136209958 doi "https://doi.org/10.3390/cancers13071516" @default.
• W3136209958 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8036952" @default.
• W3136209958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33806081" @default.
• W3136209958 hasPublicationYear "2021" @default.
• W3136209958 type Work @default.
• W3136209958 sameAs 3136209958 @default.
• W3136209958 citedByCount "4" @default.
• W3136209958 countsByYear W31362099582021 @default.
• W3136209958 countsByYear W31362099582022 @default.
• W3136209958 countsByYear W31362099582023 @default.
• W3136209958 crossrefType "journal-article" @default.
• W3136209958 hasAuthorship W3136209958A5010325047 @default.
• W3136209958 hasAuthorship W3136209958A5010436347 @default.
• W3136209958 hasAuthorship W3136209958A5011719291 @default.
• W3136209958 hasAuthorship W3136209958A5014370655 @default.
• W3136209958 hasAuthorship W3136209958A5014956643 @default.
• W3136209958 hasAuthorship W3136209958A5027656725 @default.
• W3136209958 hasAuthorship W3136209958A5029977875 @default.
• W3136209958 hasAuthorship W3136209958A5031324764 @default.
• W3136209958 hasAuthorship W3136209958A5074150271 @default.
• W3136209958 hasBestOaLocation W31362099581 @default.
• W3136209958 hasConcept C113280763 @default.
• W3136209958 hasConcept C126322002 @default.
• W3136209958 hasConcept C142724271 @default.
• W3136209958 hasConcept C143998085 @default.
• W3136209958 hasConcept C170493617 @default.
• W3136209958 hasConcept C194409129 @default.
• W3136209958 hasConcept C2989005 @default.
• W3136209958 hasConcept C2993559085 @default.
• W3136209958 hasConcept C67847695 @default.
• W3136209958 hasConcept C71924100 @default.
• W3136209958 hasConcept C80115893 @default.
• W3136209958 hasConcept C90924648 @default.
• W3136209958 hasConceptScore W3136209958C113280763 @default.
• W3136209958 hasConceptScore W3136209958C126322002 @default.
• W3136209958 hasConceptScore W3136209958C142724271 @default.
• W3136209958 hasConceptScore W3136209958C143998085 @default.
• W3136209958 hasConceptScore W3136209958C170493617 @default.
• W3136209958 hasConceptScore W3136209958C194409129 @default.
• W3136209958 hasConceptScore W3136209958C2989005 @default.
• W3136209958 hasConceptScore W3136209958C2993559085 @default.

• next